1998
DOI: 10.1002/(sici)1521-4141(199810)28:10<3221::aid-immu3221>3.0.co;2-s
|View full text |Cite
|
Sign up to set email alerts
|

Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice

Abstract: Severe combined immunodeficient (SCID) mice accept human xenografts and can act as a model for human immune functions. Murine natural killer cells (NK), however, represent an important barrier for the reconstitution of SCID mice with human peripheral blood leukocytes (Hu‐PBL). We investigated the effect on Hu‐PBL survival of pretreatment with TM‐β1, a rat monoclonal antibody for the mouse IL‐2 receptor beta chain. TM‐β1 greatly improved the survival of Hu‐PBL. Human lymphocytes, predominantly T cells, survived… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
48
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 35 publications
(50 citation statements)
references
References 37 publications
2
48
0
Order By: Relevance
“…NOD-scid-B2m null mice support heightened levels of human T cell engraftment, and in contrast to that observed in Hu-PBL-NOD-scid mice, there was a normal ratio of CD4:CD8 human cells in Hu-PBL-NOD-scid-B2m null mice (20). The basis of these differences in human cell engraftment could result from differences in host NK cell activity or from the absence of host MHC class I (20,35,36).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…NOD-scid-B2m null mice support heightened levels of human T cell engraftment, and in contrast to that observed in Hu-PBL-NOD-scid mice, there was a normal ratio of CD4:CD8 human cells in Hu-PBL-NOD-scid-B2m null mice (20). The basis of these differences in human cell engraftment could result from differences in host NK cell activity or from the absence of host MHC class I (20,35,36).…”
Section: Discussionmentioning
confidence: 99%
“…IL-2R ␤-chain (CD122) is expressed on mouse NK cells, granulocytes, and, to a lesser extent, many other cell types (37,38). Administration of TM-␤1 mAb to Hu-PBL-C.B-17-scid mice has been shown to increase human cell engraftment (36). Our present data show that human cell proliferation is increased in NOD-scid mice treated with anti-mouse CD122 mAb, and that this treatment leads to a CD4:CD8 ratio similar to that observed in NOD-scid-B2m null mice.…”
Section: Discussionmentioning
confidence: 99%
“…1 day before transplantation. TM␤1 is a rat anti-mouse anti-IL-2R ␤-chain mAb that depletes the murine NK cells (19). Human PBMC containing 3 ϫ 10 6 B lymphocytes, or a maximum of 70 ϫ 10 6 human PBMC (depending on the buffy coat), were dissolved in PBS and injected i.p.…”
Section: Transfer Of Pbmc To Scid/scid Mice and Immunization Of Scid/mentioning
confidence: 93%
“…injection. Pretreatment of SCID/SCID mice with TM g 1 significantly improves the survival and functionality of the graft [29]. HMC were dissolved in 500 ?…”
Section: Transferring Hmc To Scid/scid Micementioning
confidence: 99%